RSV
Section Editor(s): Ronald Ellis, Biotech and Biopharma, Jerusalem, IL
RSV: research, development, biotechnology, preclinical, clinical, safety, epidemiology, cost, and economics.
Filters
Show filters
More subjects within
No subjects within
Selected filters
Clear all filters
- Article Commentary Remove selected filter:
- Human Vaccines & Immunotherapeutics
- RSV
Modify your search
Human Vaccines & Immunotherapeutics sections
-
Showing 1-1 of 1 results for search:
Filters